TGM2 and celiac disease: Of the 54,541 HUNT4 participants with serum samples, 1,107 presented with positive serology (i.e., based on levels of anti-TG2, immunoglobulin A (IgA), and G (IgG)) and were eligible for invitation to the HUNT4 Coeliac Disease Study.